|
|
|
FDA Home | Search FDA Site | A-Z Index | Contact FDA
| Center | Date | Time | Location* |
|---|---|---|---|
| CBER | April 8, 2003 | 1:00 p.m. - 3:30 p.m. | Food and Drug
Administration |
Agenda:
The committee will listen to updates on FDA activities relating to allergen
extract standardization.
Procedure:
Interested persons may present data, information, or views, orally or in writing,
on issues pending before the committee. Written submissions may be made to the
contact person by April 3, 2003. Oral presentations from the public will be
scheduled between approximately 2:15 p.m. and 3:15 p.m. Time allotted for each
presentation may be limited. Those desiring to make formal oral presentations
should notify the contact person before April 4, 2003, and submit a brief statement
of the general nature of the evidence or arguments they wish to present, the
names and address of proposed participants, and an indication of the approximate
time requested to make their presentation. Persons attending FDA's advisory
committee meetings are advised that the agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the public at its advisory committee meetings and will make every effort to accommodate persons with physical disabilities or special needs. If you require special accommodations due to a disability, please contact William Freas, or Jane Brown at least 7 days in advance of the meeting.
Contact Person:
William Freas or Jane Brown, Center for Biologics Evaluation and Research (HFM-71),
Food and Drug Administration, 1401Rockville Pike, Rockville, MD 20852, 301-827-0314,
or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in
the Washington, DC area), code 12388. Please call the Information Line for up-to-date
information on this meeting.